GlassScriptPhysician profile
Dominique Jacobs
NPI 1174267504
$3,701.54
in general payments reported to CMS, 2019-2025
17 companies · $1,612 in 2025
The $1,612 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $699 · 2024: $1,282 · 2025: $1,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,323 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.33 |
| Education | $269.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $600.15 | 2023-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $562.15 | 2023-2025 | Tremfya |
| Abbvie INC. | $430.03 | 2024-2025 | |
| Genzyme Corporation | $366.26 | 2023-2025 | |
| Galderma Laboratories, L.P. | $314.24 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $285.72 | 2024-2025 | Zoryve |
| Ucb, INC. | $243.99 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $170.04 | 2025 | |
| Krystal Biotech INC | $124.74 | 2023 | Vyjuvek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.11 | 2023 | Spevigo |
| Leo Pharma INC. | $109.90 | 2024 | Adbry |
| Teva Pharmaceuticals USA, INC. | $108.24 | 2022 | |
| Dermavant Sciences, INC. | $99.01 | 2024 | Vtama |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Pfizer INC. | $36.89 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $32.29 | 2023 | |
| Incyte Corporation | $26.79 | 2023 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominique Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.